GSK’s Arexvy to lead new RSV vaccines sales race with Moderna a close second: reportGSK's Arexvy to lead new RSV vaccines sales race with Moderna a close second: report - FiercePharma fiercepharma.com Submitted by fiercepharma5012 on July 24, 2023 at 2:44 PM in health No comments 60